Medicare Enrolled
Dr. Stephanie Delgaudio-Riemann, M.D.
Optician · Woodstock, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Delgaudio-Riemann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delgaudio-Riemann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delgaudio-Riemann
Dr. Stephanie Delgaudio-Riemann is an optician specialist in Woodstock, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Delgaudio-Riemann performed 22,432 Medicare services across 2,075 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delgaudio-Riemann received a total of $199,780 from 72 pharmaceutical and/or device companies across 1429 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delgaudio-Riemann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in GA
$199,780 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,432
Medicare services
Top 2% in GA for optician
2,075
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,122 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
19,104 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,133 | $88 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
414 | $127 | $300 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
361 | $77 | $210 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
304 | $9 | $35 |
| New patient office visit, complex (60-74 min) | 177 | $161 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
162 | $156 | $535 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
134 | $25 | $50 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
98 | $353 | $949 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
91 | $109 | $360 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
79 | $0 | $15 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
68 | $94 | $180 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
68 | $25 | $75 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
68 | $26 | $75 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
45 | $70 | $213 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
33 | $1 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $121 | $350 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
25 | $36 | $80 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
20 | $214 | $575 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $64 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$199,780
Total received (2018-2024)
Avg $28,540/year across 7 years
Top 2% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,429
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168,754 (84.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,116 (12.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,910 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,572
2023
$8,624
2022
$30,980
2021
$57,162
2020
$38,456
2019
$25,711
2018
$35,275
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$482
UCB, Inc.
$453
PFIZER INC.
$255
ARGENX US, INC.
$251
Lundbeck LLC
$213
Novartis Pharmaceuticals Corporation
$175
SK Life Science, Inc.
$168
Neurocrine Biosciences, Inc.
$149
Teva Pharmaceuticals USA, Inc.
$143
Alexion Pharmaceuticals, Inc.
$140
Biogen, Inc.
$133
ACADIA Pharmaceuticals Inc
$118
Sumitomo Pharma America, Inc.
$107
Lilly USA, LLC
$98
Amgen Inc.
$98
Otsuka America Pharmaceutical, Inc.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$61
MDD US Operations, LLC
$57
SCILEX PHARMACEUTICALS INC.
$56
BANNER LIFE SCIENCES, LLC
$56
Celgene Corporation
$50
Amneal Pharmaceuticals LLC
$48
Azurity Pharmaceuticals, Inc.
$40
Genentech USA, Inc.
$34
EMD Serono, Inc.
$34
Neurelis, Inc.
$29
Eisai Inc.
$24
Harmony Biosciences Llc
$10
Top 3 companies account for 33.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$53,013
AbbVie Inc.
$40,178
Allergan, Inc.
$34,223
ABBVIE INC.
$21,488
Lundbeck LLC
$17,381
Lilly USA, LLC
$5,262
Supernus Pharmaceuticals, Inc.
$4,269
Biogen, Inc.
$2,727
E.R. Squibb & Sons, L.L.C.
$2,252
UCB, Inc.
$1,977
LivaNova USA, Inc.
$1,759
Abbott Laboratories
$1,161
ACADIA Pharmaceuticals Inc
$1,060
Amgen Inc.
$945
SK Life Science, Inc.
$737
Celgene Corporation
$734
Alexion Pharmaceuticals, Inc.
$729
Genentech USA, Inc.
$585
Novartis Pharmaceuticals Corporation
$563
PFIZER INC.
$560
Eisai Inc.
$497
Neurelis, Inc.
$426
Avanir Pharmaceuticals, Inc.
$395
ARGENX US, INC.
$384
US WorldMeds, LLC
$371
Amneal Pharmaceuticals LLC
$343
Neurocrine Biosciences, Inc.
$324
Horizon Therapeutics plc
$319
GENZYME CORPORATION
$313
Greenwich Biosciences, Inc.
$301
EMD Serono, Inc.
$296
BANNER LIFE SCIENCES, LLC
$288
Takeda Pharmaceuticals U.S.A., Inc.
$283
Allergan Inc.
$281
UPSHER-SMITH LABORATORIES LLC
$265
Adamas Pharmaceuticals, Inc.
$244
Biohaven Pharmaceutical Holding Company Ltd.
$233
Sumitomo Pharma America, Inc.
$228
Acorda Therapeutics, Inc
$154
Alfasigma USA, Inc.
$146
Nevro Corp.
$136
Arbor Pharmaceuticals, Inc.
$131
NOVARTIS PHARMACEUTICALS CORPORATION
$131
Otsuka America Pharmaceutical, Inc.
$128
Biohaven Pharmaceuticals, Inc.
$121
ARBOR PHARMACEUTICALS, INC.
$120
Kyowa Kirin, Inc.
$103
MDD US Operations, LLC
$95
Azurity Pharmaceuticals, Inc.
$94
Impax Laboratories, Inc.
$79
Avion Pharmaceuticals
$78
Bausch Health US, LLC
$77
Merz Pharmaceuticals, LLC
$75
CSL Behring
$70
Jazz Pharmaceuticals Inc.
$68
Currax Pharmaceuticals LLC
$68
Grifols USA, LLC
$62
Endo Pharmaceuticals Inc.
$61
SCILEX PHARMACEUTICALS INC.
$56
JAZZ PHARMACEUTICALS INC.
$39
Mylan Pharmaceuticals Inc.
$38
Corium, LLC
$36
Assertio Therapeutics, Inc.
$31
Alnylam Pharmaceuticals Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$27
Mallinckrodt Hospital Products Inc.
$26
Scilex Pharmaceuticals Inc.
$25
EISAI INC.
$22
AbbVie, Inc.
$20
NEUROPACE, INC.
$17
Vertical Pharmaceuticals, LLC
$15
Harmony Biosciences Llc
$10
Top 3 companies account for 63.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · CREXONT · Cenobamate · DUOPA · Dhivy · Duopa · ELYXYB - CELECOXIB · EMGALITY · Edarbyclor · Epidiolex · Fintepla · Fycompa · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · LINZESS · LYRICA · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · PAXLOVID · PLEGRIDY · Proclaim Family of SCS IPGs · QULIPTA · REXULTI · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · Senza · Senza Spinal Cord Stimulation System · Soliris · TECFIDERA · TOSYMRA · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS - Sentiva · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Vumerity · WAKIX · XYREM · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for optician in GA.
Geographic Context
Opticians within 10 mi
469
Per 100K population
170.8
County median income
$105,442
Nearest hospital
NORTHSIDE HOSPITAL CHEROKEE
7.1 mi
7.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Delgaudio-Riemann is a mixed practice specialist, with above-average Medicare volume (top 2% in GA), with speaking/promotional industry engagement in the top 2% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Delgaudio-Riemann experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Delgaudio-Riemann performed 19,104 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delgaudio-Riemann receive payments from pharmaceutical companies?
Yes. Dr. Delgaudio-Riemann received a total of $199,780 from 72 companies across 1,429 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delgaudio-Riemann's costs compare to other opticians in Woodstock?
Dr. Delgaudio-Riemann's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delgaudio-Riemann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Woodstock
Browse opticians in Woodstock ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology